Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-24-017948
Filing Date
2024-12-18
Accepted
2024-12-18 17:16:34
Documents
1
Period of Report
2024-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp222262_6k.htm 6-K 12267
  Complete submission text file 0000950103-24-017948.txt   13315
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 241560236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)